We demonstrate: 1) that contralateral breast cancer risk for patients from BRCA1/2 negative families is low and similar to the risk for patients with sporadic breast cancer; and 2) that contralateral breast cancer risk strongly depends on the mutation status and age at onset of the first breast cancer. Here, BRCA1 is linked to breast carcinoma.